Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
C-Rad AB Class B ( ($SE:CRAD.B) ) just unveiled an announcement.
C-RAD has secured an 8 MSEK service contract with a major healthcare provider on the U.S. East Coast, marking a significant step in enhancing the provider’s radiation oncology program. This agreement, which builds on a longstanding relationship, is part of C-RAD’s strategy to expand its presence in the U.S. market and underscores its commitment to improving cancer treatment outcomes through innovative, patient-centered technologies.
More about C-Rad AB Class B
C-RAD is a company specializing in surface-guided imaging solutions for radiation therapy, aiming to deliver highly accurate dose delivery to tumors while protecting healthy tissue. Their technology employs high-speed 3D cameras and augmented reality to enhance patient setup and monitor motion during treatment, ensuring safety and comfort without additional imaging doses. C-RAD is listed on NASDAQ Stockholm.
Average Trading Volume: 35,050
Current Market Cap: SEK1.22B
For detailed information about CRAD.B stock, go to TipRanks’ Stock Analysis page.